Showing 2071-2080 of 3102 results for "".
- New Data Demonstrates Long-Term Safety, Efficacy of Galderma’s RelabotulinumtoxinAhttps://modernaesthetics.com/news/new-data-demonstrates-long-term-safety-efficacy-of-galdermas-relabotulinumtoxina/2473698/Galderma presented new phase III data from the READY-4 clinical trial at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting last week. The data demonstrates the long-term safety of RelabotulinumtoxinA (RelfydessTM) for frown lines and crow’s feet after repea
- Avène Introduces Two New Topical Solutionshttps://modernaesthetics.com/news/avene-introduces-two-new-topical-solutions/2473697/French skincare brand Avène introduced Cicalfate+ Intensive Skin Restoration Serum and XeraCalm Eczema Calming Relief Balm, two new innovations that feature the company’s mineral-rich Thermal Spring Water. “These breakthrough formulations are at the heart of how Eau T
- Botox Approved for Platysma Bandshttps://modernaesthetics.com/news/botox-approved-for-platysma-bands/2473696/The US Food and Drug Administration (FDA) has approved BOTOX® Cosmetic for temporary improvement in the appearance of moderate-to-severe vertical bands connecting the jaw and neck (platysma bands) in adults, Allergan Aesthetics, an AbbVie company, announced. According to a pres
- JOYA Launches First Skin Cancer Prevention, Anti-Aging Employee Benefit Platformhttps://modernaesthetics.com/news/joya-launches-first-skin-cancer-prevention-anti-aging-employee-benefit-platform/2473695/JOYA the first employee skin health and wellness benefit platform, announced its emergence from stealth mode with $5 million in seed funding from LUX Capital, Mosaic General Partnership, Arsama Trust, and Joyance Partners. The funding will support team expansion, product developme
- L&P Aesthetics Earns Distinction for Signature Deep-Plane Facelifthttps://modernaesthetics.com/news/lp-aesthetics-earns-distinction-for-signature-deep-plane-facelift/2473692/L&P Aesthetics, located in Palo Alto and Los Gatos, California, was named Best Facial Plastic Surgery in Silicon Valley Magazine's Best of 2024. The magazine recognized the "refined approach" to the practice’s L&P Signature deep-plane facelift, which lif
- FDA Clears Accure Laser System for Acne Vulgarishttps://modernaesthetics.com/news/fda-clears-accure-laser-system-for-acne-vulgaris/2473691/The US Food and Drug Administration (FDA) cleared the Accure Laser System for the long-term treatment of patients with mild-to-severe inflammatory acne vulgaris, according to a press release from Accure Acne, Inc. "This achievement cannot be overstated," Acclure Acne co-founde
- Swollen Lip Following Filler Procedure Leads to Woman Being Diagnosed With Leukemiahttps://modernaesthetics.com/news/swollen-lip-following-filler-procedure-leads-to-woman-being-diagnosed-with-leukemia/2473688/An unexpected swollen lip during a lip filler procedure led a British woman to discover she had leukemia. In April 2023, Edita Jucaite, 36, was getting a dermal filler procedure and when it was injected into her lip it immediately swelled up. Jucaite was modeling for a dentist col
- DefenAge Skincare Product Selected as NewBeauty Readers' Choice Award Winnerhttps://modernaesthetics.com/news/defenage-skincare-product-selected-as-newbeauty-readers-choice-award-winner/2473685/DefenAge Skincare’s 3D Eye Radiance Cream was named the NewBeauty 2024 Readers’ Choice Award winner. The recognition is part of NewBeauty’s second annual Readers’ Choice Awards, celebrating products that were most recognized by beauty enthusiasts. Defe
- Epicutis® Launches Arctigenin Brightening Treatmenthttps://modernaesthetics.com/news/epicutis-launches-arctigenin-brightening-treatment/2473684/The newest addition to Epicutis’s science-based professional skincare line, which the company says treats skin health and not age, is the Arctigenin Brightening Treatment—a clean, clinically proven skin brightening treatment that Epicutis says dethrones Vitamin C as the reigning brigh
- AEON 'Aligned' With FDA for Botox Biosimilarhttps://modernaesthetics.com/news/aeon-aligned-with-fda-for-botox-biosimilar/2473682/AEON Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, announced receipt of the formal minutes from a recent Biosimilar Initial Advisory (BIA) Meeting with the US Food and Drug Administration (FDA) for AB